ARCHIVES

FDA, ASCO Meet to Review Drug Approval Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 17 | April 25, 2003

Download PDF Visit The Full Archive

Related Articles

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

H. Lee Moffitt Center Reads The Cancer Letter

July 19, 2002

Obituary: NCI’s Elaine Ron, Expert in Radiation Heath Effects

December 3, 2010

New Mexico, Michigan Win Saturation Implementation Contracts

June 6, 1975

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Lombardi Cancer Center, UDC Collaborate to Increase Cancer Awareness Among Blacks

August 3, 2001